|
An easy-to-handle DPD deficiency test in saliva to identify patients at high-risk for life-threatening toxicity due to fluoropyrimidine therapy. |
|
|
Patents, Royalties, Other Intellectual Property - Patent pending (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Anne Caroline Cezimbra da Silva |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Speakers' Bureau - Boehringer Ingelheim |
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celltrion (Inst) |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |